Search for other papers by Lian Duan in
Google Scholar
PubMed
Search for other papers by Han-Yu Zhang in
Google Scholar
PubMed
Search for other papers by Min Lv in
Google Scholar
PubMed
Search for other papers by Han Zhang in
Google Scholar
PubMed
Search for other papers by Yao Chen in
Google Scholar
PubMed
Search for other papers by Ting Wang in
Google Scholar
PubMed
Search for other papers by Yan Li in
Google Scholar
PubMed
Search for other papers by Yan Wu in
Google Scholar
PubMed
Search for other papers by Junfeng Li in
Google Scholar
PubMed
Search for other papers by Kefeng Li in
Google Scholar
PubMed
Introduction Graves’ disease (GD) is an autoimmune disease with the overproduction of thyroid-stimulating hormones (TSH) induced by the activation of thyrotropin-receptor antibodies (TRAb) ( 1 ). It is the most common cause of hyperthyroidism
Search for other papers by Nadia Sawicka-Gutaj in
Google Scholar
PubMed
Search for other papers by Ariadna Zybek-Kocik in
Google Scholar
PubMed
Search for other papers by Michał Kloska in
Google Scholar
PubMed
Search for other papers by Paulina Ziółkowska in
Google Scholar
PubMed
Search for other papers by Agata Czarnywojtek in
Google Scholar
PubMed
Search for other papers by Jerzy Sowiński in
Google Scholar
PubMed
Search for other papers by Dorota Mańkowska-Wierzbicka in
Google Scholar
PubMed
Search for other papers by Marek Ruchała in
Google Scholar
PubMed
was an observational study with consecutive enrollment. Females with newly diagnosed overt autoimmune hypo- or hyperthyroidism (Hashimoto’s disease or Graves’ disease, respectively) were included. Inclusion criteria for hypothyroid group consisted of
Search for other papers by Stavroula A Paschou in
Google Scholar
PubMed
Search for other papers by Nektaria Papadopoulou-Marketou in
Google Scholar
PubMed
Search for other papers by George P Chrousos in
Google Scholar
PubMed
Search for other papers by Christina Kanaka-Gantenbein in
Google Scholar
PubMed
more frequent in women and manifests in adulthood. Addison’s disease is the prevailing disorder with up to 70% prevalence, and it is often combined with type 1 diabetes (up to 50% prevalence in patients with the syndrome). Autoimmune thyroid disease
Search for other papers by Aglaia Kyrilli in
Google Scholar
PubMed
Search for other papers by Bernard Corvilain in
Google Scholar
PubMed
Department of Gynecology and Obstetrics, Copenhagen University Hospital (Hvidovre Hospital), Hvidovre, Denmark
Search for other papers by Sofie Bliddal in
Google Scholar
PubMed
Carelink Nærhospital, Roskilde, Denmark
Search for other papers by Dorthe Hansen Precht in
Google Scholar
PubMed
Institute of Clinical Medicine, Faculty of Health and Clinical Research, Copenhagen University, Copenhagen, Denmark
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Université Libre de Bruxelles (ULB), Brussels, Belgium
Search for other papers by Kris Poppe in
Google Scholar
PubMed
.1.8027226 ) 18 Negro R Formoso G Mangieri T Pezzarossa A Dazzi D & Hassan H . Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications . Journal of Clinical Endocrinology and
Search for other papers by Ruth Percik in
Google Scholar
PubMed
Search for other papers by Sherwin Criseno in
Google Scholar
PubMed
Search for other papers by Safwaan Adam in
Google Scholar
PubMed
Search for other papers by Kate Young in
Google Scholar
PubMed
Royal Marsden Hospital, London, UK
Search for other papers by Daniel L Morganstein in
Google Scholar
PubMed
be present, the literature to date suggests that they are less frequently detected than in classic autoimmune disease, suggesting a different mechanism of gland dysfunction. The timescale often differs as well, with rapid evolution into complete gland
Search for other papers by Erika Biegelmeyer in
Google Scholar
PubMed
Search for other papers by Iury Scanagata in
Google Scholar
PubMed
Search for other papers by Laura Alves in
Google Scholar
PubMed
Search for other papers by Murilo Reveilleau in
Google Scholar
PubMed
Search for other papers by Fernando Pereira Schwengber in
Google Scholar
PubMed
Search for other papers by Simone Magagnin Wajner in
Google Scholar
PubMed
.3%) had chronic thyroid disease, 9 (2.6) used lithium or amiodarone, while 84 (23.9%) were transferred from ICU. A total of 345 patients were included and followed-up for 6 months. Clinical, laboratory and anthropometric information were prospectively
Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Search for other papers by Li Qian in
Google Scholar
PubMed
Search for other papers by Yuxiao Zhu in
Google Scholar
PubMed
Search for other papers by Yan Luo in
Google Scholar
PubMed
Search for other papers by Mu Zhang in
Google Scholar
PubMed
Search for other papers by Liping Yu in
Google Scholar
PubMed
Search for other papers by Yu Liu in
Google Scholar
PubMed
Search for other papers by Tao Yang in
Google Scholar
PubMed
were significantly lower in the subjects with T1DM than in the controls ( P < 0.05). In both ethnic cohorts, several subjects with T1DM had autoimmune thyroid disease (AITD) or celiac disease (CD), although without significance ( P > 0.05). However
Search for other papers by Aleksandra Krygier in
Google Scholar
PubMed
Search for other papers by Ewelina Szczepanek-Parulska in
Google Scholar
PubMed
Search for other papers by Dorota Filipowicz in
Google Scholar
PubMed
Search for other papers by Marek Ruchała in
Google Scholar
PubMed
Mikos H Mikos M Rabska-Pietrzak B Niedziela M . The clinical role of serum concentrations of selected cytokines: il-1beta, TNF-alpha and IL-6 in diagnosis of autoimmune thyroid disease (AITD) in children . Autoimmunity 2014 47 466 – 472
Search for other papers by Weidi Wang in
Google Scholar
PubMed
Search for other papers by Lingjun Kong in
Google Scholar
PubMed
Search for other papers by Hongkun Guo in
Google Scholar
PubMed
Search for other papers by Xiangjin Chen in
Google Scholar
PubMed
heterogeneity. Hashimoto's thyroiditis Hashimoto's thyroiditis is a common autoimmune disease of the thyroid. This meta-analysis suggests that PTMC patients with HT exhibited a 1.56-fold higher risk of contralateral malignancy, suggesting that HT was a
Search for other papers by Xingyao Tang in
Google Scholar
PubMed
Search for other papers by Zhi-Hui Song in
Google Scholar
PubMed
Search for other papers by Dawei Wang in
Google Scholar
PubMed
Search for other papers by Jinkui Yang in
Google Scholar
PubMed
Search for other papers by Marly Augusto Cardoso in
Google Scholar
PubMed
Search for other papers by Jian-Bo Zhou in
Google Scholar
PubMed
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
Search for other papers by Rafael Simó in
Google Scholar
PubMed
by 2050 ( 2 ). Prevention of dementia is crucial owing to the lack of disease-modifying medication. Recent reports have declared that risk factor modifications could prevent 30–35% of dementia cases ( 3 ). The thyroid hormone, as a modifiable risk